Microbix Biosystems (TSE:MBX) Share Price Crosses Above 50-Day Moving Average – What’s Next?

Microbix Biosystems Inc. (TSE:MBX)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$0.23 and traded as high as C$0.26. Microbix Biosystems shares last traded at C$0.25, with a volume of 70,034 shares changing hands.

Microbix Biosystems Stock Performance

The company has a debt-to-equity ratio of 30.47, a quick ratio of 5.57 and a current ratio of 7.51. The company has a market capitalization of C$33.25 million, a price-to-earnings ratio of -8.00 and a beta of 0.40. The stock’s 50-day moving average price is C$0.23 and its 200-day moving average price is C$0.24.

Microbix Biosystems (TSE:MBX) last announced its quarterly earnings results on Thursday, February 12th. The company reported C($0.01) earnings per share (EPS) for the quarter. Microbix Biosystems had a negative net margin of 25.48% and a negative return on equity of 14.88%. The company had revenue of C$4.22 million during the quarter. As a group, equities research analysts expect that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.